About BridgeBio Pharma (BBIO)
BridgeBio Pharma, Inc. is a United States-based company, The Company discovers and develops medicines that target well-characterized genetic diseases. The Company’s product platform divided into three key categories: Mendelian, Oncology and Gene ther... Read more
- USD35.19
- USD35.20
- USD33.73
- USD41.04
- 27.30%
- 218M
- 2.84M
- 2.62M
- 5.5B
- 21.62
- -9.60%
Stock News
1 hour ago
CDC upgrades its advisory on bird flu. Will Moderna’s stock get a boost?
MarketWatch
2 hours ago
Apple slides on disappointing iPhone data in China. Here's why we're not panicking
CNBC
2 hours ago
Pack these key documents in your financial go-bag—'rifling through drawers' won't work in an emergency
CNBC
3 hours ago
Here is where Cramer stands on DuPont after key spin-off and guidance updates
CNBC
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
